MedPath

HYUNDAI BIOLAND Co., Ltd.

🇰🇷South Korea
Ownership
Public
Employees
331
Market Cap
-
Website
http://www.skbioland.com

RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)

Not Applicable
Not yet recruiting
Conditions
Guided Bone Regeneration
Interventions
Device: GBR membrane
First Posted Date
2024-08-26
Last Posted Date
2024-08-26
Lead Sponsor
Hyundai Bioland Co., Ltd.
Target Recruit Count
50
Registration Number
NCT06570265

Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus

Phase 3
Completed
Conditions
Chondral or Osteochondral Lesion of Talus
Interventions
Biological: CARTISTEM®
Procedure: Microfracture
First Posted Date
2020-03-17
Last Posted Date
2022-11-29
Lead Sponsor
Hyundai Bioland Co., Ltd.
Target Recruit Count
102
Registration Number
NCT04310215
Locations
🇰🇷

Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of

🇰🇷

Kyunghee University Medical Center, Seoul, Dongdaemun-gu, Korea, Republic of

🇰🇷

Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath